Our exploration focused on how Myoinositol, often known as Myo, impacts autoimmune disorders, particularly autoimmune thyroiditis. We learned that Myo plays a crucial role in the body's thyroid function by aiding in the production of thyroid hormones and regulating iodine, which is essential in this process.
Interestingly, when Myo was combined with Selenium in treatment, patients with subclinical hypothyroidism showed significant decreases in thyroid-stimulating hormone (TSH) levels. Additionally, levels of antithyroid autoantibodies also dropped, which is promising for those battling autoimmune thyroid issues.
However, it is important to note that the study did not exclusively isolate the effect of Myoinositol, as the results were observed in conjunction with Selenium. Therefore, while the findings are encouraging, we cannot definitively claim that Myo alone yields the same benefits in managing autoimmune disorders.
Read More
Myo-inositol enhances vitamin D effectsThe impact of vitamin D on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in myo-inositol-treated and myo-inositol-naïve women with autoimmune thyroiditis: A pilot study.
Impact of combined treatments
Our study aimed to explore the impact of myo-inositol treatment on thyroid autoimmunity in women with autoimmune thyroiditis. We included groups of women who had been on myo-inositol for a while and those who hadn’t. For six months, we observed how vitamin D supplementation interacted with myo-inositol in affecting thyroid health and immune responses.
We found that among participants taking myo-inositol, the addition of vitamin D significantly improved insulin sensitivity and led to better outcomes regarding thyroid antibodies. Specifically, women who were already on myo-inositol showed a greater reduction in thyroid peroxidase and thyroglobulin antibodies when vitamin D was added to their regimen.
Interestingly, the effects of vitamin D were less noticeable in women who weren't on myo-inositol. These individuals did not exhibit the same improvements in thyroid function or antibodies. Overall, the findings suggest that myo-inositol might enhance the benefits of vitamin D, indicating a potential synergistic effect between these two agents in managing autoimmune thyroiditis.
Read More
Cat's claw shows potential benefitsAntioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis.
Moderate relevance to treatment effectiveness
We explored the effectiveness of cat's claw in managing autoimmune disorders, specifically osteoarthritis (OA) and rheumatoid arthritis (RA). Our review included various studies, focusing on its potential as a dietary supplement to reduce inflammation and oxidative stress associated with these conditions.
From the research, we found three studies that support the use of cat's claw, whether alone or in combination with other treatments, for patients suffering from OA. However, while some evidence exists, we noted that the effectiveness of cat's claw for RA isn't as robust.
It's important to recognize, though, that the full impact of cat's claw on autoimmune disorders needs more thorough research. Many factors, including varying responses to treatment, call for caution in making solid recommendations based solely on the existing studies.
Overall, while there’s promise in using cat's claw for managing autoimmune conditions, we should approach it with realistic expectations and an understanding that further investigation is necessary before solid conclusions can be drawn.
Read More
Cat's claw shows modest RA benefitsRandomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis.
Effect of concurrent medications noted
We engaged in an interesting exploration of how a plant extract from cat's claw, specifically the pentacyclic chemotype of Uncaria tomentosa, might help those suffering from rheumatoid arthritis (RA). Our study involved forty patients who were already on medications like sulfasalazine or hydroxychloroquine, which allowed us to evaluate the extract's effectiveness in addition to these existing treatments.
Over the course of 52 weeks, we structured the study into two phases. The first 24 weeks were double-blind and placebo-controlled, meaning neither the patients nor the researchers knew who was receiving the actual cat's claw extract and who was getting a placebo. This approach adds credibility to the findings. After the initial phase, all patients received the plant extract for another 28 weeks.
Notably, we found that after 24 weeks of treatment with the cat's claw extract, patients experienced a significantly larger reduction in painful joints compared to those taking the placebo. The results highlighted a 53.2% decrease in painful joints with the extract versus 24.1% with the placebo, a finding we felt was particularly promising. Even in the second phase, where patients received the extract after an initial placebo, there were marked improvements in tender and swollen joints.
Importantly, throughout the study, we observed only minor side effects, suggesting that cat's claw is relatively safe for this patient population. Our findings indicate that this plant extract could be a modest but helpful addition for patients dealing with active rheumatoid arthritis, particularly for those who are already on other treatments.
Read More
Myo-inositol shows no benefitEffects of different supplements on Hashimoto's thyroiditis: a systematic review and network meta-analysis.
Inositol's isolated effects unclear
We aimed to understand the impact of Myo-inositol on thyroid autoantibody levels in patients with Hashimoto's thyroiditis (HT). Our analysis included data from a systematic review of several case-control studies that explored various dietary supplements, particularly focusing on inositol's effectiveness.
Our findings revealed that while selenium supplementation significantly reduced thyroid autoantibodies, the effects of Myo-inositol were not as promising. In fact, Myo-inositol, as well as Vitamin D both alone and in combination with selenium, did not produce significant reductions in either thyroid peroxidase autoantibodies (TPOAb) or thyroglobulin autoantibodies (TgAb).
This lack of efficacy suggests that Myo-inositol may not be an effective standalone treatment for lowering autoantibody levels in autoimmune disorders like HT. Therefore, we recommend that patients focus on selenium as a more impactful supplement during their treatment journey.
Read More